Accession Number: | 0001593968-23-000441 |
Date: | 2023-03-09 |
Issuer: | KARUNA THERAPEUTICS, INC. (KRTX) |
Original Submission Date: |
BRANNAN STEPHEN K.
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, 26TH FLOOR
BOSTON, MA 02110
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-03-09 | M | 5,000 | a | $5.45 | 28,650 | direct | ||
COMMON STOCK | 2023-03-09 | S | 5,000 | d | $189.51 | 23,650 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 5.45 | 2023-03-09 | deemed execution date | M | 5,000 (d) | 2027-06-01 | common stock 5,000 | $5.45 | 24,677 | direct |
ID | footnote |
---|---|
f1 | the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on april 8, 2022. |
f2 | this option vested as to 25% of the shares on the first anniversary of the vesting commencement date of march 1, 2017, with additional vesting as to 12.5% of the shares underlying the option award at the end of each six month period thereafter. |